BRKR Stock Analysis: Buy, Sell, or Hold?
BRKR - Bruker Corporation
$36.76
0.68 (1.88%)
▲
5d:
+4.02%
30d:
-4.52%
90d:
-21.97%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Distribution
BRKR is up 6.1% this week, but smart money is buying puts. Top strike: $45 2026-06-18 with 136 OI. Put ratio: 64% View Scanner →
Strength: 4.4/10
Get Alerted When BRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BRKR trading at deep discount. Market pricing in -7.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BRKR trading at deep discount. Market pricing in -7.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$71.70
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$44.52
17.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BRKR is currently trading at $36.76, which is considered fair relative to its 30-day fair value range of $34.12 to $38.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.2) compared to its historical average (19.2). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This pessimistic expectation contrasts with the company's recent 8.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BRKR is in a strong downtrend. The price is approaching resistance at $37.61. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BRKR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.86 (+30.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BRKR is in a strong downtrend. The price is approaching resistance at $37.61. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BRKR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $47.86 (+30.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$34.12 -
$38.90
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.2% below Wall St target ($47.86)
Fair Price Analysis
30-Day Fair Range
$34.12 -
$38.90
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$33.11
Resistance Level
$37.61
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.21
Wall Street Target
$47.86
(+30.2%)
Revenue Growth (YoY)
-0.2%
Earnings Growth (YoY)
8.5%
Profit Margin
-0.2%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
15.2 vs 19.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$34.00
(-8%)
2-Year Target
$31.45
(-14%)
3-Year Target
$29.09
(-21%)
3-Yr Target (if PE normalizes)
(PE: 15→19)
$36.73
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 14.3%)
$74.16
(+102%)
Base:
(SPY PE: 15.2, Growth: 14.3%)
$54.83
(+49%)
Bear:
(PE: 12.9, Growth: 14.3%)
$46.60
(+27%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.2 to 19.2
Stabilization Target:
$46.41
(+26.3%)
PE Expansion Potential:
+26.3%
Share & Embed Analysis
Last updated: April 03, 2026 1:20 AM ET
Data refreshes hourly during market hours. Next update: 2:20 AM
Data refreshes hourly during market hours. Next update: 2:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Munch
SELL
2000 shares
2026-03-13
Mark Munch
SELL
2000 shares
2026-01-15
Mark Munch
SELL
7000 shares
2026-01-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
Advanced BRKR Option Strategies
Professional options setups generated by AI based on today's BRKR price and gamma walls.
